Phosphoinositide-3-kinase inhibition elevates ferritin level resulting depletion of labile iron pool and blocking of glioma cell proliferation.

[1]  Nupur K. Das,et al.  Leishmania donovani inhibits ferroportin translation by modulating FBXL5‐IRP2 axis for its growth within host macrophages , 2018, Cellular microbiology.

[2]  S. Rivella,et al.  A Red Carpet for Iron Metabolism , 2017, Cell.

[3]  J. Connor.  Role of H-Ferritin in Radiosensitivity of Human Glioma Cells , 2016 .

[4]  F. Gaboriau,et al.  Recent advances in cancer treatment by iron chelators. , 2016, Bioorganic & medicinal chemistry letters.

[5]  Nupur K. Das,et al.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.

[6]  P. Seth,et al.  Role of extracellular Hydrogen peroxide in regulation of iron homeostasis genes in neuronal cells: Implication in iron accumulation. , 2015, Free radical biology & medicine.

[7]  D. Richardson,et al.  Targeting cancer by binding iron: Dissecting cellular signaling pathways , 2015, Oncotarget.

[8]  J. Tainer,et al.  Emerging critical roles of Fe-S clusters in DNA replication and repair. , 2015, Biochimica et biophysica acta.

[9]  C. Legendre,et al.  Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies , 2015, Trends in Endocrinology & Metabolism.

[10]  P. Seth,et al.  Astrocytes mediate HIV‐1 Tat‐induced neuronal damage via ligand‐gated ion channel P2X7R , 2015, Journal of neurochemistry.

[11]  C. Mukhopadhyay,et al.  Catecholamine Stress Hormones Regulate Cellular Iron Homeostasis by a Posttranscriptional Mechanism Mediated by Iron Regulatory Protein , 2015, The Journal of Biological Chemistry.

[12]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[13]  K. Frei,et al.  Targeting Class IA PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma , 2014, PloS one.

[14]  K. Shah,et al.  Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384 , 2014, Cancer biology & therapy.

[15]  L. Miller,et al.  IRP2 regulates breast tumor growth. , 2014, Cancer research.

[16]  J. Connor,et al.  The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. , 2013, Biochimica et biophysica acta.

[17]  P. Subramanian,et al.  Each Member of the Poly-r(C)-binding Protein 1 (PCBP) Family Exhibits Iron Chaperone Activity toward Ferritin* , 2013, The Journal of Biological Chemistry.

[18]  F. Torti,et al.  Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.

[19]  J. Connor,et al.  Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents. , 2011, Cancer research.

[20]  F. Torti,et al.  Ironing out cancer. , 2011, Cancer research.

[21]  P. Seth,et al.  Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS , 2010, Journal of NeuroVirology.

[22]  H. Wakimoto,et al.  A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models. , 2011, Cancer research.

[23]  S. Robinson,et al.  Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. , 2010, The Biochemical journal.

[24]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[25]  Eric C. Holland,et al.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.

[26]  W. Weiss,et al.  Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance. , 2010, Current topics in microbiology and immunology.

[27]  R. Eisenstein,et al.  Regulatory Protein Binding and Regulatory Hierarchy Multiple Determinants within Iron-responsive Elements Dictate Iron Material Supplemental Multiple Determinants within Iron-responsive Elements Dictate Iron Regulatory Protein Binding and Regulatory Hierarchy , 2022 .

[28]  Paul Workman,et al.  Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma , 2009, Cell cycle.

[29]  C. Mukhopadhyay,et al.  Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3′-Untranslated Region , 2009, Journal of Biological Chemistry.

[30]  Nupur K. Das,et al.  Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth , 2008, Cellular microbiology.

[31]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[32]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[33]  Quan-guang Zhang,et al.  Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.

[34]  S. Rosenkranz,et al.  PI3‐kinase/Akt‐dependent antiapoptotic signaling by the PDGF α receptor is negatively regulated by Src family kinases , 2006, FEBS letters.

[35]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[36]  T. Rouault,et al.  Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. , 2006, Cell metabolism.

[37]  G. Mills,et al.  Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma , 2005, British journal of haematology.

[38]  A. Opstal,et al.  Inhibitors of phosphatidylinositol 3-kinase activity prevent cell cycle progression and induce apoptosis at the M/G1 transition in CHO cells , 2006, Cellular and Molecular Life Sciences CMLS.

[39]  Guangjun Nie,et al.  Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. , 2004, Blood.

[40]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[41]  S. Koyasu.  Role of class IA phosphoinositide 3-kinase in B lymphocyte development and functions. , 2004, Biochemical Society transactions.

[42]  K. Hinchliffe,et al.  Phosphatidylinositol phosphate kinases. , 2004, Journal of endocrinological investigation.

[43]  G. Reifenberger,et al.  Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐lnositol‐3′‐Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in Glioblastomas , 2003, Brain pathology.

[44]  M. J. Fry,et al.  The phosphoinositide (PI) 3-kinase family , 2003, Journal of Cell Science.

[45]  Paul S Mischel,et al.  Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. , 2003, Cancer research.

[46]  D. Richardson,et al.  The role of iron in cell cycle progression and the proliferation of neoplastic cells. , 2002, Biochimica et biophysica acta.

[47]  M. Linder,et al.  Iron Prevents Ferritin Turnover in Hepatic Cells* , 2001, The Journal of Biological Chemistry.

[48]  D. Cantrell.  Phosphoinositide 3-kinase signalling pathways. , 2001, Journal of cell science.

[49]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[50]  S. Abboud,et al.  A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.

[51]  B. Vanhaesebroeck,et al.  The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.

[52]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[53]  C. Beaumont,et al.  H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. , 1999, Blood.

[54]  D. Richardson.  Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia. , 1998, Leukemia & lymphoma.

[55]  D. Richardson.  Potential of iron chelators as effective antiproliferative agents. , 1997, Canadian journal of physiology and pharmacology.

[56]  F. McCormick,et al.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. , 1997, Science.

[57]  R. Klausner,et al.  Requirements for iron‐regulated degradation of the RNA binding protein, iron regulatory protein 2. , 1995, The EMBO journal.

[58]  S. Roberts,et al.  Ferritin iron kinetics and protein turnover in K562 cells. , 1988, The Journal of biological chemistry.

[59]  E. Gelfand,et al.  Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation , 1984 .